Status:
COMPLETED
Effects of Remote Ischemic Preconditioning During Free Flap Reconstruction
Lead Sponsor:
Seoul National University Hospital
Conditions:
Remote Ischemic Preconditioning
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Remote ischemic preconditioning (RIPC) has been revealed organ-protective effect in many previous clinical settings including coronary intervention or cardiovascular surgery. However its protective ro...
Detailed Description
Patients undergoing free flap reconstructive surgery for head and neck cancer will be randomized to either remote ischemic preconditioning (RIPC) group or control group. On the day of surgery, after i...
Eligibility Criteria
Inclusion
- patients undergoing free flap reconstructive surgery
Exclusion
- BMI \< 18, \> 35 kg/m\^2
- AV fistula at arm, any reason to protect arm
- vascular abnormality or discomfort at arm
- peripheral vascular disease, peripheral neuropathy, or coagulopathy
- uncontrolled diabetes mellitus
- preoperative use of beta-blocker
- history of radiation therapy
- refuse to enrol
Key Trial Info
Start Date :
April 13 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 9 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03474952
Start Date
April 13 2018
End Date
December 9 2019
Last Update
March 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 03080